Clinical Trial: A Study of the Effect of Multiple Doses of Diltiazem on the Plasma Levels of MK-6916 in Healthy Participants (MK-6916-005)

U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT06818968) titled 'A Study of the Effect of Multiple Doses of Diltiazem on the Plasma Levels of MK-6916 in Healthy Participants (MK-6916-005)' on Feb. 05.

Brief Summary: The goal of the study is to learn what happens to levels of MK-6916 in a healthy person's body over time. Researchers will compare what happens to MK-6916 in the body when it is given with or without another medicine called diltiazem.

Study Start Date: Feb. 27

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: MK-6916

Oral administration

DRUG: Diltiazem

Oral administration

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Merck Sharp & Dohme LLC

Disclaimer: Cu...